1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United States Pharmaceuticals and Healthcare Report Q1 2016

United States Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 111 pages

Includes 3 FREE quarterly updates

BMI View:

The US pharmaceutical market will continue to display robust growth over the medium term despite efforts from the public and private sectors to reduce drug spending. Many newly launched patented drugs that have clear efficacy and safety benefits are able to command premium prices from payers. This external validation provides buoyancy to the industry, which has been recently accused of price gouging.


Headline

Expenditure Projections

- Pharmaceuticals: USD309.9bn in 2014 to USD326.9bn in 2015; +5.5% growth. Historic market size revised downwards significantly since Q315 due to adoption of new data source.
- Healthcare: USD3,006.4bn in 2014 to USD3,121.0bn in 2015; +3.8% growth. Forecast unchanged since Q315.

Table Of Contents

United States Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United States 2013-2019) . 7
SWOT . 10
Industry Forecast .. 12
Pharmaceutical Market Forecast . 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (United States 2011-2019) 14
Healthcare Market Forecast . 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2011-2019) . . 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2011-2019) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2011-2019) . . 20
Prescription Drug Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United States 2011-2019) . . 23
Patented Drug Market Forecast .. 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United States 2011-2019) 25
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United States 2011-2019) . 28
OTC Medicine Market Forecast .. 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United States 2011-2019) . 31
Pharmaceutical Trade Forecast .. 32
Table: Pharmaceutical Trade Data And Forecasts (United States 2013-2019) 33
Industry Risk Reward Index 34
Americas Risk/Reward Index 34
United States Risk/Reward Index . 41
Rewards .. 41
Risks . 41
Regulatory Review 43
Intellectual Property Issues . 58
Pricing and Reimbursement Regime . 59
Late-2013 Government Shutdown .. 61
Market Overview 64
Healthcare Sector . 65
Table: Key Features Of The Affordable Care Act By Year 67
Table: Healthcare Resources (United States 2009-2014) . 70
Table: Healthcare Personnel (United States 2009-2014) . 70
Table: Healthcare Activity (United States 2009-2014) . 71
Clinical Trials 71
Epidemiology . 73
Competitive Landscape . 76
Research-Based Industry . 76
Table: Multinational Market Activity . 77
Pharmaceutical Distribution .. 78
Company Profile . 79
Amgen 79
AstraZeneca . 83
Eli Lilly . 87
GlaxoSmithKline . 90
Merck and Co .. 93
Pfizer . 97
Demographic Forecast 100
Table: Population Headline Indicators (United States 1990-2025) . . 101
Table: Key Population Ratios (United States 1990-2025) 101
Table: Urban/Rural Population and Life Expectancy (United States 1990-2025) . 102
Table: Population By Age Group (United States 1990-2025) . . 102
Table: Population By Age Group % (United States 1990-2025) . . 103
Glossary 105
Methodology .. 107
Pharmaceutical Expenditure Forecast Model .. 107
Healthcare Expenditure Forecast Model 107
Notes On Methodology .. 108
Risk/Reward Index Methodology . 109
Index Overview 110
Table: Pharmaceutical Risk/Reward Index Indicators 110
Indicator Weightings . 111

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.